TH17 Cell Induction and Effects of IL-17A and IL-17F Blockade in Experimental Colitis
EG Wedebye Schmidt, HL Larsen… - Inflammatory bowel …, 2013 - academic.oup.com
Background T helper (TH) 17 cells are believed to play a pivotal role in development of
inflammatory bowel disease, and their contribution to intestinal inflammation has been …
inflammatory bowel disease, and their contribution to intestinal inflammation has been …
Neutralizing IL-23 is superior to blocking IL-17 in suppressing intestinal inflammation in a spontaneous murine colitis model
Background IL-23/TH17 inflammatory responses are regarded as central to the
pathogenesis of inflammatory bowel disease, but clinically IL-17A antibodies have shown …
pathogenesis of inflammatory bowel disease, but clinically IL-17A antibodies have shown …
Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis
LP McLean, RK Cross, T Shea-Donohue - Immunotherapy, 2013 - Taylor & Francis
Evaluation of: Wedebye Schmidt EG, Larsen HL, Kristensen N et al. Th17 cell induction and
effects of IL-17A and IL-17F blockade in experimental colitis. Inflamm. Bowel Dis. 19 (8) …
effects of IL-17A and IL-17F blockade in experimental colitis. Inflamm. Bowel Dis. 19 (8) …
Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ Dependent
G Nizzoli, C Burrello, FM Cribiù, G Lovati… - Journal of Crohn's …, 2018 - academic.oup.com
Background and Aims T helper 17 [Th17] cells are crucially involved in the
immunopathogenesis of inflammatory bowel diseases in humans. Nevertheless …
immunopathogenesis of inflammatory bowel diseases in humans. Nevertheless …
Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production
Abstract Both Th1 and Th17 cells have been implicated in the pathogenesis of inflammatory
bowel disease and experimental colitis. However, the complex relationship between Th1 …
bowel disease and experimental colitis. However, the complex relationship between Th1 …
Monoclonal anti–interleukin 23 reverses active colitis in a T cell–mediated model in mice
Background & Aims: Interleukin (IL)-23 supports a distinct lineage of T cells producing IL-17
(Th17) that can mediate chronic inflammation. This study was performed to define the role of …
(Th17) that can mediate chronic inflammation. This study was performed to define the role of …
Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease
G Hundorfean, MF Neurath… - Inflammatory bowel …, 2012 - academic.oup.com
The recent discovery and characterization of T helper 17 cells (Th17) and their signature
cytokines (IL-17) represents a hallmark in T-cell immunobiology by providing a new …
cytokines (IL-17) represents a hallmark in T-cell immunobiology by providing a new …
Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease
CM Wilke, L Wang, S Wei, I Kryczek, E Huang… - Journal of Translational …, 2011 - Springer
Background Th17 cells play a role in inflammation. Interleukin (IL)-10 is a potent anti-
inflammatory cytokine. However, it is poorly understood whether and how endogenous IL-10 …
inflammatory cytokine. However, it is poorly understood whether and how endogenous IL-10 …
Th17-related cytokines in inflammatory bowel diseases: friends or foes?
I Monteleone, M Sarra, F Pallone… - Current molecular …, 2012 - ingentaconnect.com
T helper (Th) 17 cells and other interleukin (IL)-17-producing cells are supposed to play
critical roles in several human immune-mediated diseases, including Crohn's disease (CD) …
critical roles in several human immune-mediated diseases, including Crohn's disease (CD) …
Il-23/Il-17 Axis in IBD
M Sarra, F Pallone, TT MacDonald… - Inflammatory bowel …, 2010 - academic.oup.com
Gut inflammation occurring in patients with Crohn's disease and patients with ulcerative
colitis has been traditionally associated with an exaggerated Th1 or Th2 cell response …
colitis has been traditionally associated with an exaggerated Th1 or Th2 cell response …